Publikationen, an denen er mitarbeitet Vicent Fonollosa Pla (22)

2020

  1. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

    Scientific Reports, Vol. 10, Núm. 1

2016

  1. Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies

    Arthritis and Rheumatology, Vol. 68, Núm. 9, pp. 2338-2344

  2. LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition

    Clinical and Experimental Rheumatology

2015

  1. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis

    Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35

2014

  1. A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility

    Arthritis Research and Therapy, Vol. 16, Núm. 1

2013

  1. A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci

    Human Molecular Genetics, Vol. 22, Núm. 19, pp. 4021-4029

  2. Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 7, pp. 1233-1238

  3. New insight on the Xq28 association with systemic sclerosis

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 12, pp. 2032-2038

2012

  1. Analysis of class II human leucocyte antigens in Italian and Spanish systemic sclerosis

    Rheumatology, Vol. 51, Núm. 1, pp. 52-59

  2. Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis

    Arthritis Research and Therapy, Vol. 14, Núm. 3

  3. Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis

    Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1275-1279

  4. Evidence that deletion at FCGR3B is a risk factor for systemic sclerosis

    Genes and Immunity, Vol. 13, Núm. 6, pp. 458-460

  5. Identification of CSK as a systemic sclerosis genetic risk factor through genome wide association study follow-up

    Human Molecular Genetics, Vol. 21, Núm. 12, pp. 2825-2835

  6. Influence of the IL6 gene in susceptibility to systemic sclerosis

    Journal of Rheumatology, Vol. 39, Núm. 12, pp. 2294-2302

  7. No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and systemic sclerosis

    Tissue Antigens, Vol. 80, Núm. 3, pp. 254-258

  8. Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expression

    Journal of Rheumatology, Vol. 39, Núm. 1, pp. 112-118

  9. The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis

    Genes and Immunity, Vol. 13, Núm. 2, pp. 191-196

2011

  1. A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort

    Annals of the Rheumatic Diseases, Vol. 70, Núm. 4, pp. 638-641

  2. Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis

    Annals of the Rheumatic Diseases, Vol. 70, Núm. 3, pp. 454-462

  3. Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis

    Annals of the Rheumatic Diseases